Predicted to enable enzyme binding activity and transcription corepressor activity. Predicted to be involved in negative regulation of hematopoietic stem cell differentiation; negative regulation of transcription by RNA polymerase II; and positive regulation of hematopoietic stem cell proliferation. Predicted to act upstream of or within blastocyst development. Predicted to be part of transcription repressor complex. Predicted to be active in nucleus. Orthologous to human N4BP2L2 (NEDD4 binding protein 2 like 2). [provided by Alliance of Genome Resources, Apr 2022]